Gkiozos I - Search Results

1

Triplet combination of carboplatin, irinotecan, and etoposide in the first-line treatment of extensive small-cell lung cancer: a single-institution phase II study.

Charpidou A, Tsagouli S, Tsimpoukis S, Vassias A, Makrilia N, Stratakos G, Gkiozos I, Syrigos K. Charpidou A, et al. Among authors: gkiozos i. Anticancer Drugs. 2010 Jul;21(6):651-5. doi: 10.1097/CAD.0b013e3283393718. Anticancer Drugs. 2010. PMID: 20386306 Clinical Trial.

2

Developments in the treatment of non-small cell lung cancer.

Gkiozos I, Charpidou A, Syrigos K. Gkiozos I, et al. Anticancer Res. 2007 Jul-Aug;27(4C):2823-7. Anticancer Res. 2007. PMID: 17695454 Free article. Review.

3

Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients.

Karapanagiotou EM, Polyzos A, Dilana KD, Gratsias I, Boura P, Gkiozos I, Syrigos KN. Karapanagiotou EM, et al. Among authors: gkiozos i. Lung Cancer. 2009 Dec;66(3):393-8. doi: 10.1016/j.lungcan.2009.02.006. Epub 2009 Mar 17. Lung Cancer. 2009. PMID: 19282046

4

Therapy-induced toxicity of the lungs: an overview.

Charpidou AG, Gkiozos I, Tsimpoukis S, Apostolaki D, Dilana KD, Karapanagiotou EM, Syrigos KN. Charpidou AG, et al. Among authors: gkiozos i. Anticancer Res. 2009 Feb;29(2):631-9. Anticancer Res. 2009. PMID: 19331213 Free article. Review.

5

Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients.

Karapanagiotou EM, Terpos E, Dilana KD, Alamara C, Gkiozos I, Polyzos A, Syrigos KN. Karapanagiotou EM, et al. Among authors: gkiozos i. Med Oncol. 2010 Jun;27(2):332-8. doi: 10.1007/s12032-009-9214-z. Epub 2009 Apr 17. Med Oncol. 2010. PMID: 19373566

6

Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: a single institution phase II study.

Ralli M, Tourkantonis I, Makrilia N, Gkini E, Kotteas E, Gkiozos I, Katirtzoglou N, Syrigos K. Ralli M, et al. Among authors: gkiozos i. Anticancer Res. 2009 Aug;29(8):3441-4. Anticancer Res. 2009. PMID: 19661370 Free article. Clinical Trial.

7

Carboplatin-pemetrexed adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC): a phase II study.

Karapanagiotou EM, Boura PG, Papamichalis G, Konstantinou M, Sepsas E, Chamalakis G, Simsiris P, Gkiozos I, Syrigos KN. Karapanagiotou EM, et al. Among authors: gkiozos i. Anticancer Res. 2009 Oct;29(10):4297-301. Anticancer Res. 2009. PMID: 19846990 Free article. Clinical Trial.

8

Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study.

Katirtzoglou N, Gkiozos I, Makrilia N, Tsaroucha E, Rapti A, Stratakos G, Fountzilas G, Syrigos KN. Katirtzoglou N, et al. Among authors: gkiozos i. Clin Lung Cancer. 2010 Jan;11(1):30-5. doi: 10.3816/CLC.2010.n.005. Clin Lung Cancer. 2010. PMID: 20085865 Clinical Trial.

9

Metastin is not involved in metastatic potential of non-small cell lung cancer.

Karapanagiotou EM, Dilana KD, Gkiozos I, Gratsias I, Tsimpoukis S, Polyzos A, Syrigos KN. Karapanagiotou EM, et al. Among authors: gkiozos i. Med Oncol. 2011 Jun;28(2):559-64. doi: 10.1007/s12032-010-9466-7. Epub 2010 Mar 6. Med Oncol. 2011. PMID: 20213218

10

Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients.

Charpidou A, Gkiozos I, Konstantinou M, Eleftheraki A, Demertzis P, Harrington K, Polyzos A, Syrigos KN. Charpidou A, et al. Among authors: gkiozos i. Cancer Lett. 2011 May 28;304(2):144-53. doi: 10.1016/j.canlet.2011.02.018. Cancer Lett. 2011. PMID: 21396771 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters